1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. HALOZYME THERAPEUTICS INC.
Halozyme Therapeutics Inc. XNAS: HALO
Mid-range Performer
Download real time
58.08 1.48 (2.61%)
36.18% Gain from 52W Low
503.5K
XNAS Volume

XNAS 16 Jul, 2025 1:45 PM (EDT)

Watchlist

Portfolio

Alert

Share
16S
4W
0O
3T
57.9

Day RSI

RSI is mid-range
38.2

Day MFI

MFI is mid-range
0.0

Beta 1Year

Very Low volatility
55.3

50Day SMA

Price above SMA 55.3
55.4

200Day SMA

Price above SMA 55.4
Insider Trade
Helen Torley, President & CEO of Halozyme Therapeutics, sells 60K shares worth $3.4 million See details

Halozyme Therapeutics Inc. RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Halozyme Therapeutics Inc. technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis